Cart
sales@molnova.com
Neurokinin A(4-10) TFA(97559-35-8 free base)
CAS No. ——
Neurokinin A(4-10) TFA(97559-35-8 free base)( —— )
Catalog No. M30084 CAS No. ——
Neurokinin A (4-10) TFA is a tachykinin NK2 receptor agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameNeurokinin A(4-10) TFA(97559-35-8 free base)
-
NoteResearch use only, not for human use.
-
Brief DescriptionNeurokinin A (4-10) TFA is a tachykinin NK2 receptor agonist.
-
DescriptionNeurokinin A (4-10) TFA is a tachykinin NK2 receptor agonist.(In Vitro):Neurokinin A (NKA) and its truncated form NKA(4-10) are potent spasmogens of human colon circular muscle, an action mediated exclusively via tachykinin NK2 receptors. A structure-activity study of the neurokinin A (NKA) fragment NKA(4-10) is performed to investigate the importance of amino acid residues for receptor efficacy, potency and affinity at the NK2 receptor in human colon circular muscle. A high density of NK2 receptors has been demonstrated in this tissue, using in vitro autoradiography and radioligand binding.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorNK2 receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight880.93
-
Molecular FormulaC36H55F3N8O12S
-
Purity>98% (HPLC)
-
SolubilityH2O : < 0.1 mg/mL (insoluble)
-
SMILES——
-
Chemical NameSequence:Asp-Ser-Phe-Val-Gly-Leu-Met-NH2
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Warner FJ, et al. Structure-activity relationship of neurokinin A(4-10) at the human tachykinin NK(2) receptor: the effect of amino acid substitutions on receptor affinity and function. Biochem Pharmacol. 2002 Jun 15;63(12):2181-6.
molnova catalog
related products
-
Boc-Val-Cit-OH
Boc-Val-Cit-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
-
6-Methoxywogonin
6-Methoxywogonin shows weak anti-inflammatory effect.
-
(-)-Syringaresinol 4...
(-)-Syringaresinol inhibits the proliferation of human promyelocytic HL-6 cells through G(1) arrest and induction of apoptosis, may be a potential chemotherapeutic agent for the treatment of cancer.
